Annexon Biosciences (ANNX): Net earnings per share growth forecast for next year
The 12-month forward EPS trajectory reflects Annexon, Inc. (ANNX) environmental initiatives to optimize energy consumption and waste disposal. Upward revisions to forecasts are supported by patent protection for C1q protein blocking mechanisms, although a narrow specialization in the complement pathway maintains binary risks. Meanwhile, the 3.00 metric serves as the target level determining the fundamental development vector of the neuropharmaceutical business.
Analytical breakdowns for Annexon (ANNX)
- price and consensus price forecast:
- stock exchange capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- earnings and market ratios statistics:
ANNX - Company Profit|Expected Profit Annexon, Inc.|ANNX - Price to Earnings Multiple|Projected Price to Earnings Annexon Inc.|ANNX - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Annexon Biosciences Inc.|ANNX - Operating profit before amortization|Net earnings per share (EPS TTM) Annexon|ANNX - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months annexonbio.com|ANNX - Earnings growth in current year|Net earnings per share growth forecast for next year Annexon, Inc.
- sales and revenue indicators:
Comprehensive company analysis:annexonbio.com
The biopharmaceutical model of Annexon, Inc. (ANNX) with high R&D expenditures makes the forward-looking net earnings per share growth a critical indicator. This metric measures the expected change in EPS by weighing future patent revenues against current operating expenses. Positive momentum here signals a transition from the testing phase to monopoly margins, which determines the fundamental stability of the asset prior to market entry.
Competitor analysis
Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Expected earnings per share trend next year XENE|Viking Therapeutics - Earnings growth forecast for next year|Expected earnings per share trend next year SUPN (supernus.com)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Denali (DNLI)|Net earnings per share growth forecast for next year harmonybiosciences.com|BHVN (Biohaven Pharmaceutical) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year amylyx.com (AMLX)|TRVI: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Praxis Precision Medicines Inc PRAX|Consensus forecast of earnings per share growth for next year Anavex Life Sciences Corp. (AVXL)|CeriBell EEG - Earnings growth forecast for next year|Expected net earnings per share growth next year Prothena Corp|ALEC: Earnings growth forecast for next year|OMER: Projected earnings per share increase next year|NGNE (neurogene.com) - Earnings growth forecast for next year|Earnings growth forecast for next year AC Immune S.A.|Expected earnings per share growth for next year VYGR (Voyager Therapeutics, Inc.)|Projected earnings per share increase next year NMRA|Net earnings per share growth forecast for next year scilexholding.com SCLX|TVGN: Projected earnings per share growth rate for next year|alphacognition.com - Earnings growth forecast for next year|Cognition Therapeutics - Projected earnings per share increase next year|IKT: Earnings growth forecast for next year|Expected earnings per share growth for next year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year Coya Therapeutics (COYA)|Expected earnings per share growth for next year VTGN (Vistagen)|Consensus forecast of earnings per share growth for next year Ovid Therapeutics Inc|Earnings growth forecast for next year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Expected earnings per share growth for next year|Alterity Therapeutics Limited - Earnings growth forecast for next year|Expected net earnings per share growth next year Clene Inc|PEPG: Earnings growth forecast for next year|Expected earnings per share growth for next year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth forecast for next year|Earnings growth forecast for next year Annovis Bio Corporation|Earnings growth forecast for next year GRCE|AIFF: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|NRSN: Projected earnings per share growth rate for next year|RVPH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year MetaVia MTVA|neuraxis.com (NRXS) - Net earnings per share growth forecast for next year|Helius Medical Technologies Inc. - Expected earnings per share trend next year|PASG (Passage Bio, Inc.) - Earnings growth forecast for next year|bionomics.com.au - Net earnings per share change forecast for next year|Earnings growth forecast for next year NERV|ATHA (Athira) - Expected earnings per share trend next year|Addex Therapeutics - Expected earnings per share growth for next year|ALZN - Expected earnings per share growth for next year|Cyclerion Therapeutics, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year CRGT|Expected earnings per share growth for next year ATXI|Expected earnings per share growth for next year Brainstorm Cell (BCLI)|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Expected earnings per share growth for next year Chromocell Therapeutics Corp CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics, Inc.)|Earnings growth forecast for next year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth forecast for next year|NeuroBo Pharmaceuticals Inc - Expected earnings per share trend next year|SAGE (Sage Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year SNPX (Neurotrope)|Net earnings per share growth forecast for next year Trevena Inc. (TRVN)|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year
